- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Natalizumab antibody from the original Tysabri® commercial drug.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
alpha-4 integrin |
Monoclonal Antibody |
Tysabri® |
20 mg/mL |
– |
4 mg |
-80°C |
02/2025 |
261,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin